Post by youngStartup Ventures

📈 Investor Spotlight: Ephraim Lindenbaum | Advance Ventures 📈 YoungStartup Ventures Investor Network Advance Ventures is a Silicon Valley-based venture investment fund and venture accelerator investing in seed and early-stage startups. Founded in 1999 by a unique team of proven entrepreneurs, company operators and venture capitalists, they have consistently achieved meaningful exits with its portfolio companies across its core market sectors. The fund invests in early-stage companies across high-growth technology sectors, including digital health, medtech, AI, enterprise software, sustainability, foodtech, agtech, fintech, infrastructure, and communications. The firm focuses on actively assisting entrepreneurs build great companies by dedicating significant time to each portfolio company and leveraging deep domain expertise in our investment sectors ……………… Ephraim Lindenbaum is the Managing Director and co-founder, and currently serves on the boards of Advance Ventures portfolio companies: Acerro, Front Range Biosciences, Joule Case, Myco Technology, NeuroDyne, PathogenDx, QI-Path, and Willow Industries. His previous board roles with successful exits include Agnitia Networks (acquired by LeadingEdge), Alpha Foods (acquired by Livekindly), Bright Light Systems (acquired by Phoenix), Corvigo (acquired by NASDAQ: TMWD), eSports (acquired by Ositech), iLoopMobile (acquired by LSE: IMO), Inertia Beverage Group (now WineDirect), Kite.io (acquired by Quixey), LandSonar (acquired by Triangle), MerchEngines (acquired by NASDAQ: DLX), Ooba Beverages (acquired by HealthyBrands), Parago (acquired by NASDAQ: HAWK), Smaato (acquired by Spearhead), and SnapMD (acquired by Kinderhook). Prior to co-founding Advance Ventures, Ephraim was a co-founder of interactive media pioneer Broadcast Production Group, serving as CEO until its pre-IPO acquisition by Parago in 1999. He lectures at Stanford University Graduate School of Business, Santa Clara University, San Jose State University, and UC Berkeley. Ephraim has been featured in Forbes, Inc. Magazine, VentureBeat, Wired, CNN FutureWatch, and the Silicon Valley Business Journal. One recent investment, NeuroDyne, a healthcare tech company Ephraim first connected with at #VentureSummitWest. …………… Representative Investments NeuroDyne Inc is a healthcare tech company focused on advancing innovation in the healthcare and medical technology space. Ephraim first connected with the company at Venture Summit West ’25 before Advance Ventures made a strategic investment. MycoTechnology, Inc. is a food tech company focused on using mushroom-based fermentation and ingredient innovation to improve food products. Ephraim brought MycoTechnology to the Venture Summit West stage as a premier presenter. PathogenDx develops molecular testing technology designed to support faster, more efficient pathogen detection across healthcare, food safety, and related markets. Join Us at Venture Summit West 2026 Link in comments 👇